Eatris annual meeting Dec 2018

12. 12. 2018

Our representatives participated in the annual meeting of EATRIS, the European Infrastructure for Translational Medicine, in Ljubljana. Assoc. Prof. Irena Koutná and Dr. Pavel Šimara from our Cell & Tissue Engineering Facility presented a poster on their new cGMP facility built in our center. Only few institutions in the Czech Republic have the capacity to produce cell-based medicinal products or tissue engineered products under cGMP conditions and FNUSA-ICRC now belongs among them. Representatives of FNUSA-ICRC also met potential research partners from France, Italy, Norway and Spain and started discussion on potential collaborations. EATRIS is an EU research infrastructure consortium that comprises more than 90 research institutions from 12 European countries. It focuses on accelerating medical discoveries to clinical development through international collaboration of top-level European academic research centers. FNUSA-ICRC is a member since early 2017.

Our representatives participated in the annual meeting of EATRIS
Cooperation with Oxford Uni - FNUSA-ICRC

7. 12. 2018

The Interventional Cardiac Electrophysiology Research Group, namely Tomasz Jadczyk with the support of Technology Transfer Office, has established a scientific collaboration with University of Oxford. The ICE research team led by Zdeněk Stárek, MD, PhD, will cooperate with the Department of Computer Science, University of Oxford, led by Prof. Blanca Rodriguez, PhD. The aim of a joint project is to apply machine learning methods for automatic ECG analysis. Results of the study may help to classify ECG phenotypes and support innovative treatment strategies.

Interventional Cardiac Electrophysiology Research Group FNUSA-ICRC
FNUSA-ICRC and PrimeCell

26. 11. 2018

FNUSA-ICRC and a Czech company PrimeCell established a research consortium on innovative regenerative medicine with several Israeli partners, Alpha Net, Pres-By Vision and Chelotech. A memorandum on research cooperation was signed by all partners at the end of November in Jerusalem during an opening ceremony of a state visit of the President of the Czech Republic to Israel. The Czech-Israeli research consortium will deal with the use of human cellular products to treat various types of diseases.

FNUSA-ICRC and a Czech company PrimeCell established a research consortium - Photo 1FNUSA-ICRC and a Czech company PrimeCell established a research consortium - Photo 2
FNUSA-ICRC - velvyslanec Nick Archer

21. 11. 2018

FNUSA-ICRC cooperates extensively with British scientists and research institutions, despite the British exit from the European Union. FNUSA-ICRC researchers are currently involved in the implementation of several international research projects funded by the European Union's Horizon 2020 research program, such as the CresPace project led by University of Bath in southwestern England, which aims to develop a new bio-electronic pacemaker, or ES-Cat project led by the University of Cambridge, which focuses on searching new proteins and their use in medicine or biotechnology. In cooperation with a Liverpool company, FNUSA-ICRC is trying to develop antibodies against the onset of Alzheimer's disease – this project has been financially supported by the South Moravian Region. Bilateral co-operation in science and innovation is very much supported by the new Ambassador who has identified this area as one of the major priorities.

Velvyslanec Spojeného království Velké Británie a Severního Irska v České republice Nick Archer - Foto 1Velvyslanec Spojeného království Velké Británie a Severního Irska v České republice Nick Archer - Foto 2
Medica logo

15. 11. 2018

Between November 12 and 15, FNUSA-ICRC took part in MEDICA trade fair for medical technologies in Düsseldorf. The trade fair has a long tradition and is one of the largest and most prestigious events of its kind in the world. The Czech Republic was represented by more than twenty companies and the organization of the stands was sponsored by the CzechTrade agency and the Ministry of Industry and Trade of the Czech Republic. Our center has participated in a project of this scale for the first time and presented its activities and possibilities of cooperation to a wide range of visitors and exhibitors, including both manufacturing, research and distribution companies operating around the world. Representatives of the FNUSA-ICRC Technology Transfer were offering for example the possibility of testing new medical technologies or laboratory services to potential customers. In addition to getting new contacts, we also met with our past and present partners, such as VUT or BioVendor.

FNUSA-ICRC Medica 2019 - Photo 1FNUSA-ICRC Medica 2019 - Photo 2FNUSA-ICRC Medica 2019 - Photo 3
Medica Conference Official Banner 2018
Kick-off ENOCH project

26. 10. 2018

A kick-off meeting of the unique Molecular, Cell and Clinical Approach to Healthy Aging (ENOCH) project was held in the premises of FNUSA-ICRC. The participants discussed key activities focusing on identifying the treatment of aging affecting diseases, such as dementia, cancer or heart diseases. The ambition of the project is not immortal life but healthy aging in the least burdened by diseases. The unification of the five best Moravian research centers represents a milestone in regional cooperation as it connects 220 researchers from FNUSA-ICRC, the Institute of Molecular and Translation Medicine at Palacký University in Olomouc (IMTM), the Regional Centre of Applied Molecular Oncology of the Masaryk Oncological Institute (RECAMO), the Department of Neurology at the Faculty of Medicine, Olomouc University Hospital, and the Blood Cancer Research Group at Ostrava University (BCRG).

More information on ENOCH available here
Go to top